Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

A complainant shared four third-party posts on X (formerly Twitter) and two online articles with the PMCPA to make the case ...

Moderna stock tumbled after the Senate Finance Committee voted to send RFK Jr.'s nomination for the HHS secretary to the full ...

Valued at $13.1 billion by market cap, Cambridge, Massachusetts-based Moderna, Inc. (MRNA) operates as a clinical-stage ...

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

Delving into the details, we found 51% of traders were bullish, while 25% showed bearish tendencies. Out of all the trades we ...

Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...

Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...

We recently published a list of These 10 Stocks Were Wednesday’s Worst Performers. In this article, we are going to take a ...

Bullish option flow detected in Moderna (MRNA) with 87,666 calls trading, 1.3x expected, and implied vol increasing over 2 points to 78.38%.

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.